Kindred Healthcare, Inc. (NYSE:KND) Receives Average Recommendation of “Hold” from Brokerages
Kindred Healthcare, Inc. (NYSE:KND) has earned a consensus rating of “Hold” from the nine research firms that are covering the stock, MarketBeat reports. Five analysts have rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $9.83.
KND has been the topic of a number of recent research reports. Zacks Investment Research cut shares of Kindred Healthcare from a “hold” rating to a “sell” rating in a report on Thursday. Barclays PLC reaffirmed a “buy” rating and issued a $13.00 target price (up from $11.00) on shares of Kindred Healthcare in a report on Sunday, May 7th. Mizuho reaffirmed a “neutral” rating and issued a $9.00 target price on shares of Kindred Healthcare in a report on Monday, July 3rd. Finally, Royal Bank of Canada reaffirmed a “hold” rating and issued a $10.00 target price on shares of Kindred Healthcare in a report on Monday, May 15th.
Kindred Healthcare (NYSE KND) traded up 3.21% during mid-day trading on Monday, reaching $11.25. 1,037,803 shares of the company’s stock traded hands. Kindred Healthcare has a 52 week low of $5.65 and a 52 week high of $12.55. The stock’s market capitalization is $963.37 million. The stock’s 50 day moving average is $10.51 and its 200-day moving average is $8.73.
Kindred Healthcare (NYSE:KND) last announced its earnings results on Wednesday, May 3rd. The health services provider reported $0.04 EPS for the quarter, meeting analysts’ consensus estimates of $0.04. The business had revenue of $1.77 billion for the quarter, compared to analysts’ expectations of $1.78 billion. Kindred Healthcare had a negative net margin of 9.55% and a positive return on equity of 4.08%. On average, equities analysts anticipate that Kindred Healthcare will post $0.52 EPS for the current year.
Several large investors have recently modified their holdings of KND. BlackRock Inc. raised its stake in shares of Kindred Healthcare by 41,968.4% in the first quarter. BlackRock Inc. now owns 10,779,191 shares of the health services provider’s stock valued at $90,006,000 after buying an additional 10,753,568 shares during the last quarter. Wellington Management Group LLP raised its stake in Kindred Healthcare by 40.9% in the first quarter. Wellington Management Group LLP now owns 7,945,247 shares of the health services provider’s stock valued at $66,342,000 after buying an additional 2,307,814 shares in the last quarter. Point72 Asset Management L.P. raised its stake in Kindred Healthcare by 303.1% in the first quarter. Point72 Asset Management L.P. now owns 1,734,899 shares of the health services provider’s stock valued at $14,486,000 after buying an additional 1,304,499 shares in the last quarter. Norges Bank acquired a new stake in Kindred Healthcare during the fourth quarter valued at approximately $8,342,000. Finally, Bogle Investment Management L P DE acquired a new stake in Kindred Healthcare during the first quarter valued at approximately $3,085,000. Institutional investors own 89.56% of the company’s stock.
About Kindred Healthcare
Kindred Healthcare, Inc is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.
Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.